Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yosuke Fujii

Showing results (61-70 of 77) with videos related to

Pageof 8
Sort By:
Liver Cancer|July 9, 2021
Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 TrialMasatoshi Kudo, Kenta Motomura, Yoshiyuki Wada, et al.
Child Psychiatry and Human Development|February 24, 2022
Trends in Prescribing Antipsychotics for Children and Adolescents in Japan: A Descriptive Epidemiological Study Using a Large-Scale Pharmacy DatasetSayuri Nakane, Sachiko Tanaka-Mizuno, Chika Nishiyama, et al.
Journal of Human Genetics|August 25, 2018
Correction: Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in JapanHidehiko Miyake, Shigehito Yamada, Yosuke Fujii, et al.
Journal of Human Genetics|July 1, 2016
Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in JapanHidehiko Miyake, Shigehito Yamada, Yosuke Fujii, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|September 16, 2016
Is the timing of surgery associated with avascular necrosis after unstable slipped capital femoral epiphysis? A multicenter studyYusuke Kohno, Yasuharu Nakashima, Toshio Kitano, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2025
Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17 signaling via degradation of <i>NFKBIZ</i> mRNAEriko Iguchi, Atsushi Takai, Natsumi Oe, et al.
International Journal of Hematology|December 26, 2014
A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemiaChiaki Nakaseko, Naoto Takahashi, Kenichi Ishizawa, et al.
Liver Cancer|June 12, 2018
Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II StudyMasatoshi Kudo, Yoon-Koo Kang, Joong-Won Park, et al.
International Journal of Hematology|October 28, 2019
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemiaNaohito Fujishima, Toshiki Uchida, Yasushi Onishi, et al.
Cancer Medicine|April 15, 2016
A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumorsToshihiko Doi, Kyung-Hun Lee, Tae-Min Kim, et al.
Pageof 8

Showing results (61-70 of 77) with videos related to

Sort By:
Pageof 8
Liver Cancer|July 9, 2021
Avelumab in Combination with Axitinib as First-Line Treatment in Patients with Advanced Hepatocellular Carcinoma: Results from the Phase 1b VEGF Liver 100 TrialMasatoshi Kudo, Kenta Motomura, Yoshiyuki Wada, et al.
Child Psychiatry and Human Development|February 24, 2022
Trends in Prescribing Antipsychotics for Children and Adolescents in Japan: A Descriptive Epidemiological Study Using a Large-Scale Pharmacy DatasetSayuri Nakane, Sachiko Tanaka-Mizuno, Chika Nishiyama, et al.
Journal of Human Genetics|August 25, 2018
Correction: Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in JapanHidehiko Miyake, Shigehito Yamada, Yosuke Fujii, et al.
Journal of Human Genetics|July 1, 2016
Nationwide survey for current clinical status of amniocentesis and maternal serum marker test in JapanHidehiko Miyake, Shigehito Yamada, Yosuke Fujii, et al.
Journal of Orthopaedic Science : Official Journal of the Japanese Orthopaedic Association|September 16, 2016
Is the timing of surgery associated with avascular necrosis after unstable slipped capital femoral epiphysis? A multicenter studyYusuke Kohno, Yasuharu Nakashima, Toshio Kitano, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 3, 2025
Epithelial Regnase-1 inhibits colorectal tumor growth by regulating IL-17 signaling via degradation of <i>NFKBIZ</i> mRNAEriko Iguchi, Atsushi Takai, Natsumi Oe, et al.
International Journal of Hematology|December 26, 2014
A phase 1/2 study of bosutinib in Japanese adults with Philadelphia chromosome-positive chronic myeloid leukemiaChiaki Nakaseko, Naoto Takahashi, Kenichi Ishizawa, et al.
Liver Cancer|June 12, 2018
Regional Differences in Efficacy, Safety, and Biomarkers for Second-Line Axitinib in Patients with Advanced Hepatocellular Carcinoma: From a Randomized Phase II StudyMasatoshi Kudo, Yoon-Koo Kang, Joong-Won Park, et al.
International Journal of Hematology|October 28, 2019
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemiaNaohito Fujishima, Toshiki Uchida, Yasushi Onishi, et al.
Cancer Medicine|April 15, 2016
A phase I study of the human anti-activin receptor-like kinase 1 antibody PF-03446962 in Asian patients with advanced solid tumorsToshihiko Doi, Kyung-Hun Lee, Tae-Min Kim, et al.
Pageof 8